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Innate Sensing of Chitin and Chitosan
Chelsea L. Bueter, Charles A. Specht, Stuart M. Levitz*
Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America
Chitin is the second most common polysaccharide found in
nature. It is present in crustacean shells, insect exoskeletons,
parasitic nematode eggs and gut linings, and in the cell wall of
fungi. The deacetylated derivative of chitin, chitosan, is less
common but is particularly evident in certain species of fungi, such
as Cryptococcus, and the cyst wall of Entamoeba. How mammals sense
and respond to these polymers is not well understood, and
conflicting reports on their immunological activity have led to
some controversy. Despite this, promising translational applica-
tions that exploit the unique properties of chitin and chitosan are
being developed.
What Are Chitin and Chitosan?
Chitin, a linear, neutrally charged polymer of b-(1,4)-linked N-
acetylglucosamine (GlcNAc), and its deacetylated derivative
chitosan, a cationic polymer of glucosamine (GlcN), are two
naturally occurring polysaccharides (Figure 1). Using cytoplasmic
stores of UDP-GlcNAc, chitin synthases (EC 2.4.1.16) extrude
chitin through the plasma membrane to an extracellular location
[1]. Chitin deacetylases (EC 3.5.1.41), if present, remove the acetyl
group following extrusion. During synthesis, chitin polymers
anneal to one another, typically in opposite orientation (a-chitin),
to form fibers of high tensile strength [2]. The fibers are cross-
linked with glucans in fungi to form a meshwork reinforcing the
cell wall and with protein in insect exoskeletons to give an ordered,
laminate structure to the cuticle. Chitinases (EC 3.2.1.14) and
chitosanases (EC 3.2.1.132) secreted by bacteria and fungi recycle
gigatons of chitin/chitosan to GlcNAc/GlcN annually. In their
more specialized roles, chitinases are important in developmental
processes, such as remodeling the fungal cell wall and shedding old
cuticle (molting) by crustaceans. For organisms that do not
synthesize chitin, plant and mammalian chitinases aid in defense
against chitin-bearing pathogens.
Commercial preparations of the polymers typically begin with
isolation of chitin from crustacean shell waste, followed by
chemical deacetylation to chitosan using high temperature and
strong alkali. Particulate crystals of chitin are insoluble while
chitosan is soluble in dilute acid. Commercial preparations of both
polymers vary with regard to degrees of acetylation, polymer
lengths, particle size, and contamination [3,4]. Such heterogeneity
likely accounts for some of the conflicting results in the literature.
How Are Chitin and Chitosan Recognized by
Mammals?
The lack of chitin or chitosan in mammalian cells makes these
polymers potential targets for recognition by the innate immune
system. Though chitin and possibly chitosan in their native
environment can be stained with low molecular weight dyes, they
are not readily accessed by protein-sized probes. Their exposure
requires some degree of degeneration of their surrounding
architecture, as occurs in damaged cells or fungal/crustacean
detritus [3]. Upon exposure chitin can be recognized by
mammalian chitinases, which bind and actively degrade chitin,
and chitinase-like proteins, which also bind chitin but are
catalytically inactive. It has become evident that this family of
chitin-binding proteins (Glycosyl Hydrolase Family 18) plays an
active role in inflammation and innate and adaptive immunity
based on their upregulation during various disease states [5].
Both chitin and chitosan particles are readily phagocytosed [4],
supporting a role for recognition via specific receptor(s) mediating
phagocytosis. Receptors on myeloid cells that bind chitin or
chitosan and induce a phagocytic response have yet to be
definitively identified. However, several receptors have been
shown to have an affinity for chitin or chitin oligosaccharides,
including: FIBCD1, a homotetrameric 55-kDa type II transmem-
brane protein expressed in the gastrointestinal tract [6]; NKR-P1,
an activating receptor on rat natural killer cells [7]; RegIIIc, a
secreted C-type lectin [8]; and galectin-3, a lectin with affinity for
b-galactosides [9]. However, none of these has yet been shown to
act as a receptor as opposed to a protein that binds chitin. Also,
receptors that recognize soluble oligosaccharides as by-products of
chitinase digestion may not recognize full-length, insoluble chitin.
What Kind of Responses Does Chitin Elicit in
Mammals?
Exposure to chitin, either through food or inhalation, is
common. Chitin has been shown to induce a response similar to
the response generated in helminth and allergic immunity, with an
accumulation of eosinophils and basophils expressing IL-4, and
alternatively activated macrophages [10]. Conversely, chitin
downregulated the allergic response to ragweed in mice [11].
Also, asthma/allergic conditions feature alternatively activated
macrophages, which have high expression levels of chitinases and
chitinase-like proteins. Blocking acidic mammalian chitinase
(AMCase) or knocking out BRP-39 (chitinase-like protein) results
in decreased inflammation and eosinophilia [12].
Three innate immune receptors, Toll-like receptor (TLR) 2,
Dectin-1, and the mannose receptor, have been implicated in
mediating a variety of immune responses to chitin. However, how
this occurs is not well understood. Direct binding to chitin has not
been demonstrated, and the possibility that contaminants are
responsible for some of these effects cannot be excluded. One
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study showed chitin acting via an apparent Dectin-1 dependent,
but mincle (a C-type lectin), TLR2, and TLR4-independent
mechanism could partially block cytokine production in response
to Candida albicans [3]. Nevertheless, chitin was not shown to
directly interact with Dectin-1. However, TLR2 was found to
contribute to sensing of chitin by keratinocytes [13] and chitin-
induced expression of IL-17A and IL-17AR [14]. Moreover,
TNFa and IL-10 induced by chitin appeared to be mediated by
TLR2, Dectin-1, and the mannose receptor. Interestingly, the size
of the chitin particles determined the type of response observed:
smaller fragments (,40 mm) induced cytokines that inhibited
tissue inflammation, modest-sized fragments (40–70 mm) induced
a strong pro-inflammatory response, and larger fragments were
relatively inert [15]. Finally, though chitin preparations of varying
sizes did not stimulate IL-1b production, chitosan was shown to
activate the NLRP3 inflammasome, leading to robust IL-1b
responses by a phagocytosis-dependent mechanism [4].
How Do Plants Recognize and Respond to Chitin
and Chitosan?
Fungi are major crop pathogens. It is not surprising then that
plants exhibit a wide variety of defense responses to chitin and
chitosan following fungal infestation, including increases in
chitinase expression, proteinase inhibitors, reactive oxygen species
(ROS), cytoplasmic acidification, and expression of early respon-
sive genes and defense genes [16]. Presumably, most of these
responses have developed to fight fungal infections, though chitin-
binding lectins have also been shown to have insecticidal activity
[17]. Likewise, fungi have developed methods to avoid recognition
of chitin and thereby prevent the effective antifungal response,
such as masking chitin with a-1,3-glucan, a compound plants are
unable to digest [18]. Conversely, recognition of modified chitin
oligosaccharides is important for symbiotic relationships between
leguminous plants and rhizobial bacteria [19].
A number of receptors in plants that bind directly to chitin or
mediate the response to chitin have been identified. Chitin elicitor-
binding proteins (CEBiP) containing an extracellular lysin motif
(LysM) that binds chitin directly are conserved across multiple
plant species. CEBiP knockdown in suspension-cultured rice cells
results in an absence of ROS generation in response to chitin [20].
CERK1, the Arabidopsis CEBiP homolog, is essential for chitin
elicitor signaling; dimerization upon binding is critical for MAPK
activation, ROS generation, and gene expression in response to
chitin [21]. In contrast, chitosan appears to elicit activity from
plant cells via charge-charge interactions with negatively charged
phospholipids instead of via a receptor-specific interaction [22].
Whether analogous charge-based, receptor-free interactions be-
tween mammalian cells and this highly positively charged polymer
occur is speculative.
How Are These Polymers Being Used
Translationally?
The unique structural and biological properties of chitin and
chitosan are increasingly being exploited for use in biomedical
applications, such as tissue scaffolds and wound dressings. This has
been facilitated by advances in technology to produce purified
polymers with desired physical properties. For example, particle
size can be manipulated to control the resulting inflammatory
Figure 1. Chitin and chitosan: from source to consequence. Chitin and chitosan are naturally found in fungal cell walls, crustacean shells,
nematodes eggs and gut linings, and insect exoskeletons. These polymers consist of long chains of N-acetylglucosamine (chitin) or glucosamine
(chitosan). Conversion between the two polysaccharides can be performed chemically or happen within the organisms via chitin deacetylases.
Mammalian exposure to the polymers has been linked to both upregulation and downregulation of inflammatory responses, including those
involved in asthma. Despite this, chitin and chitosan are being utilized in a variety of biomedical applications, including tissue engineering and drug
delivery.
doi:10.1371/journal.ppat.1003080.g001
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response. The polycationic properties of chitosan are being
developed for use in biosensors by immobilizing enzymes, in
wound dressings to induce cell migration and proliferation at the
wound site, and in tissue engineering as a scaffold [23].
The polycationic and biodegradable properties of chitosan
make it attractive as a controlled delivery system for conjugated
materials. Mucosal vaccines adjuvanted with chitosan have elicited
robust antibody and T-cell responses [24]. Similarly, chitosan has
been shown to have potential utility as a delivery system for drugs
and genes [25]. Although there appears to be promising future
applications for these polymers, currently chitin and chitosan are
approved by the US Food and Drug Administration only for use as
food additives. However, there are a number of ongoing clinical
trials looking to expand their approved roles.
Conclusions
Recent research has begun to clarify when and how mammals
and plants recognize and respond to exposure to chitin and
chitosan. Nevertheless, there are still many unanswered questions.
Disparities in the literature regarding the immunological activity of
chitin and chitosan are likely due in large part to the relative purity
and heterogeneity of the glycan preparations used as stimuli. In
particular, recent studies have demonstrated an inverse relation-
ship between particle size and immunological activity. While much
progress has been made in elucidating how plants recognize chitin
and chitosan, the principal receptor(s) responsible for mammalian
recognition remain to be determined. Finally, the biodegradable
and physicochemical properties of chitin and chitosan make these
glycans ideal for a wide range of translational applications.
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